TW201345908A - 吡唑并〔１，５-ａ〕嘧啶化合物 - Google Patents

Info

Publication number

TW201345908A

TW201345908A TW102126081A TW102126081A TW201345908A TW 201345908 A TW201345908 A TW 201345908A TW 102126081 A TW102126081 A TW 102126081A TW 102126081 A TW102126081 A TW 102126081A TW 201345908 A TW201345908 A TW 201345908A

Authority

TW

Taiwan

Prior art keywords

group

chlorophenyl

alkyl

pyrimidine

pyrazolo

Prior art date

2006-07-05

Links

• Espacenet
• Global Dossier
• Discuss

• -1 pyrazolo [1,5-a] pyrimidine compound Chemical class 0.000 title claims abstract description 129
• 125000000217 alkyl group Chemical group 0.000 claims abstract description 216
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 94
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 57
• 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 54
• 150000003839 salts Chemical class 0.000 claims abstract description 34
• 229910052717 sulfur Inorganic materials 0.000 claims abstract description 31
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims abstract description 26
• 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 22
• 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 19
• 125000004434 sulfur atom Chemical group 0.000 claims abstract description 17
• 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
• 150000001875 compounds Chemical class 0.000 claims description 389
• LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical compound N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 claims description 153
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 119
• 125000005843 halogen group Chemical group 0.000 claims description 98
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 84
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 82
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 69
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 55
• 229920006395 saturated elastomer Polymers 0.000 claims description 55
• 125000003545 alkoxy group Chemical group 0.000 claims description 52
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 48
• 150000001412 amines Chemical class 0.000 claims description 48
• 125000003277 amino group Chemical group 0.000 claims description 44
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 41
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 32
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 31
• 125000001424 substituent group Chemical group 0.000 claims description 29
• 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 25
• 125000004076 pyridyl group Chemical group 0.000 claims description 23
• 125000002950 monocyclic group Chemical group 0.000 claims description 18
• 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 17
• 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 claims description 17
• 239000003795 chemical substances by application Substances 0.000 claims description 17
• 125000004430 oxygen atom Chemical group O* 0.000 claims description 16
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 14
• 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 claims description 13
• 125000004103 aminoalkyl group Chemical group 0.000 claims description 13
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 13
• 125000004432 carbon atom Chemical group C* 0.000 claims description 13
• 125000001072 heteroaryl group Chemical group 0.000 claims description 13
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 11
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
• 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 10
• 239000003814 drug Substances 0.000 claims description 9
• 125000001041 indolyl group Chemical group 0.000 claims description 8
• 238000011282 treatment Methods 0.000 claims description 8
• 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims description 7
• YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims description 7
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 7
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 7
• 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 claims description 7
• 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims description 7
• PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims description 7
• KAMHJIGNJYVODO-UHFFFAOYSA-N S(=O)(=O)=C1NN2C(N=CC=C2)=C1 Chemical compound S(=O)(=O)=C1NN2C(N=CC=C2)=C1 KAMHJIGNJYVODO-UHFFFAOYSA-N 0.000 claims description 6
• 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 6
• 201000010099 disease Diseases 0.000 claims description 6
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 5
• 208000035475 disorder Diseases 0.000 claims description 5
• 208000011117 substance-related disease Diseases 0.000 claims description 5
• BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 5
• 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 4
• HNLHRHVMCSLZEN-UHFFFAOYSA-N 1h-pyrazolo[1,5-a]pyrimidine-2-thione Chemical compound N1=CC=CN2NC(=S)C=C21 HNLHRHVMCSLZEN-UHFFFAOYSA-N 0.000 claims description 4
• 208000024827 Alzheimer disease Diseases 0.000 claims description 4
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 4
• 230000000202 analgesic effect Effects 0.000 claims description 4
• ANQJSMDXQQNXPK-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine-2-sulfonamide Chemical compound N1=CC=CN2N=C(S(=O)(=O)N)C=C21 ANQJSMDXQQNXPK-UHFFFAOYSA-N 0.000 claims description 4
• 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 4
• 125000006624 (C1-C6) alkoxycarbonylamino group Chemical group 0.000 claims description 3
• 208000019901 Anxiety disease Diseases 0.000 claims description 3
• 208000024172 Cardiovascular disease Diseases 0.000 claims description 3
• 208000008589 Obesity Diseases 0.000 claims description 3
• 208000022531 anorexia Diseases 0.000 claims description 3
• 230000036506 anxiety Effects 0.000 claims description 3
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
• 206010061428 decreased appetite Diseases 0.000 claims description 3
• 229940079593 drug Drugs 0.000 claims description 3
• 239000003623 enhancer Substances 0.000 claims description 3
• 235000020824 obesity Nutrition 0.000 claims description 3
• 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims description 3
• 201000000980 schizophrenia Diseases 0.000 claims description 3
• 230000005586 smoking cessation Effects 0.000 claims description 3
• 229940124597 therapeutic agent Drugs 0.000 claims description 3
• 239000013598 vector Substances 0.000 claims description 3
• KDTUHGXEVKEQDB-UHFFFAOYSA-N 1-sulfonyl-2h-pyridin-1-ium Chemical compound O=S(=O)=[N+]1CC=CC=C1 KDTUHGXEVKEQDB-UHFFFAOYSA-N 0.000 claims description 2
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
• 208000000044 Amnesia Diseases 0.000 claims description 2
• 208000031091 Amnestic disease Diseases 0.000 claims description 2
• 208000027559 Appetite disease Diseases 0.000 claims description 2
• 208000020925 Bipolar disease Diseases 0.000 claims description 2
• 208000028698 Cognitive impairment Diseases 0.000 claims description 2
• 208000016192 Demyelinating disease Diseases 0.000 claims description 2
• 206010012735 Diarrhoea Diseases 0.000 claims description 2
• 206010013654 Drug abuse Diseases 0.000 claims description 2
• 208000012661 Dyskinesia Diseases 0.000 claims description 2
• 208000014094 Dystonic disease Diseases 0.000 claims description 2
• 206010014612 Encephalitis viral Diseases 0.000 claims description 2
• 208000019454 Feeding and Eating disease Diseases 0.000 claims description 2
• 206010016654 Fibrosis Diseases 0.000 claims description 2
• 208000018522 Gastrointestinal disease Diseases 0.000 claims description 2
• 208000010412 Glaucoma Diseases 0.000 claims description 2
• 208000032456 Hemorrhagic Shock Diseases 0.000 claims description 2
• 208000023105 Huntington disease Diseases 0.000 claims description 2
• 208000001953 Hypotension Diseases 0.000 claims description 2
• 206010061218 Inflammation Diseases 0.000 claims description 2
• 208000019695 Migraine disease Diseases 0.000 claims description 2
• 206010028980 Neoplasm Diseases 0.000 claims description 2
• 208000036110 Neuroinflammatory disease Diseases 0.000 claims description 2
• 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims description 2
• 206010033664 Panic attack Diseases 0.000 claims description 2
• 208000018737 Parkinson disease Diseases 0.000 claims description 2
• 206010039966 Senile dementia Diseases 0.000 claims description 2
• 206010040070 Septic Shock Diseases 0.000 claims description 2
• 206010049771 Shock haemorrhagic Diseases 0.000 claims description 2
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 2
• 206010044565 Tremor Diseases 0.000 claims description 2
• 206010047700 Vomiting Diseases 0.000 claims description 2
• 230000006986 amnesia Effects 0.000 claims description 2
• 208000006673 asthma Diseases 0.000 claims description 2
• 201000011510 cancer Diseases 0.000 claims description 2
• 230000002490 cerebral effect Effects 0.000 claims description 2
• 230000001684 chronic effect Effects 0.000 claims description 2
• 230000007882 cirrhosis Effects 0.000 claims description 2
• 208000019425 cirrhosis of liver Diseases 0.000 claims description 2
• 208000010877 cognitive disease Diseases 0.000 claims description 2
• 230000003111 delayed effect Effects 0.000 claims description 2
• 208000010118 dystonia Diseases 0.000 claims description 2
• 206010015037 epilepsy Diseases 0.000 claims description 2
• 230000036543 hypotension Effects 0.000 claims description 2
• 208000026278 immune system disease Diseases 0.000 claims description 2
• 208000015181 infectious disease Diseases 0.000 claims description 2
• 208000000509 infertility Diseases 0.000 claims description 2
• 230000036512 infertility Effects 0.000 claims description 2
• 231100000535 infertility Toxicity 0.000 claims description 2
• 230000004054 inflammatory process Effects 0.000 claims description 2
• 206010022437 insomnia Diseases 0.000 claims description 2
• 230000000968 intestinal effect Effects 0.000 claims description 2
• 206010027599 migraine Diseases 0.000 claims description 2
• 201000006417 multiple sclerosis Diseases 0.000 claims description 2
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 2
• 230000003959 neuroinflammation Effects 0.000 claims description 2
• 208000019906 panic disease Diseases 0.000 claims description 2
• 208000033808 peripheral neuropathy Diseases 0.000 claims description 2
• 208000020016 psychiatric disease Diseases 0.000 claims description 2
• 230000036303 septic shock Effects 0.000 claims description 2
• 230000000391 smoking effect Effects 0.000 claims description 2
• 230000002992 thymic effect Effects 0.000 claims description 2
• 201000002498 viral encephalitis Diseases 0.000 claims description 2
• 230000008673 vomiting Effects 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 6
• 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 4
• 206010012335 Dependence Diseases 0.000 claims 3
• 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 2
• 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims 2
• 208000032841 Bulimia Diseases 0.000 claims 1
• 206010006550 Bulimia nervosa Diseases 0.000 claims 1
• 229940123158 Cannabinoid CB1 receptor antagonist Drugs 0.000 claims 1
• 206010057852 Nicotine dependence Diseases 0.000 claims 1
• 208000003782 Raynaud disease Diseases 0.000 claims 1
• 208000012322 Raynaud phenomenon Diseases 0.000 claims 1
• 208000025569 Tobacco Use disease Diseases 0.000 claims 1
• 208000000323 Tourette Syndrome Diseases 0.000 claims 1
• 208000016620 Tourette disease Diseases 0.000 claims 1
• 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
• FPNYBFDGNUUERO-UHFFFAOYSA-N [7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-2-yl]methanol Chemical compound FC(C1=CC=C(C=C1)C1=CC=NC=2N1N=C(C2)CO)(F)F FPNYBFDGNUUERO-UHFFFAOYSA-N 0.000 claims 1
• 239000004480 active ingredient Substances 0.000 claims 1
• 230000003444 anaesthetic effect Effects 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 239000003555 cannabinoid 1 receptor antagonist Substances 0.000 claims 1
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 206010027175 memory impairment Diseases 0.000 claims 1
• 230000003449 preventive effect Effects 0.000 claims 1
• ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 1
• 208000014001 urinary system disease Diseases 0.000 claims 1
• 125000004414 alkyl thio group Chemical group 0.000 abstract description 11
• 125000003107 substituted aryl group Chemical group 0.000 abstract description 7
• 125000001931 aliphatic group Chemical group 0.000 abstract description 5
• 238000009739 binding Methods 0.000 abstract description 4
• 125000004122 cyclic group Chemical group 0.000 abstract description 2
• 230000000694 effects Effects 0.000 abstract description 2
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract description 2
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 291
• 239000000243 solution Substances 0.000 description 160
• 239000000203 mixture Substances 0.000 description 151
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 139
• 239000002904 solvent Substances 0.000 description 110
• 235000019439 ethyl acetate Nutrition 0.000 description 109
• 239000011541 reaction mixture Substances 0.000 description 106
• 239000000843 powder Substances 0.000 description 89
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 79
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 76
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 74
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 72
• 239000012044 organic layer Substances 0.000 description 72
• 239000012043 crude product Substances 0.000 description 70
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 67
• 238000006243 chemical reaction Methods 0.000 description 60
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 58
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 54
• 238000001816 cooling Methods 0.000 description 54
• 239000000706 filtrate Substances 0.000 description 54
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 51
• 239000002585 base Substances 0.000 description 46
• 238000004440 column chromatography Methods 0.000 description 45
• 239000007787 solid Substances 0.000 description 44
• 239000007858 starting material Substances 0.000 description 42
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 37
• 235000019341 magnesium sulphate Nutrition 0.000 description 37
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 36
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
• IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 35
• 125000004390 alkyl sulfonyl group Chemical group 0.000 description 34
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 33
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 31
• 238000000034 method Methods 0.000 description 31
• 235000019441 ethanol Nutrition 0.000 description 28
• 125000004385 trihaloalkyl group Chemical group 0.000 description 28
• 125000003118 aryl group Chemical group 0.000 description 27
• 238000003756 stirring Methods 0.000 description 22
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
• 239000007795 chemical reaction product Substances 0.000 description 21
• 238000001914 filtration Methods 0.000 description 21
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
• 125000002768 hydroxyalkyl group Chemical group 0.000 description 20
• 239000002244 precipitate Substances 0.000 description 19
• 239000012267 brine Substances 0.000 description 18
• 229960004132 diethyl ether Drugs 0.000 description 18
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 18
• 125000000753 cycloalkyl group Chemical group 0.000 description 17
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 15
• 125000000468 ketone group Chemical group 0.000 description 15
• 239000000741 silica gel Substances 0.000 description 15
• 229910002027 silica gel Inorganic materials 0.000 description 15
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 14
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 14
• 239000011593 sulfur Substances 0.000 description 14
• NMVVJZXGEJPLBD-UHFFFAOYSA-N tert-butyl n-(1-carbamoylcyclohexyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1(C(N)=O)CCCCC1 NMVVJZXGEJPLBD-UHFFFAOYSA-N 0.000 description 14
• NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 14
• 125000002619 bicyclic group Chemical group 0.000 description 13
• 239000000499 gel Substances 0.000 description 13
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
• 125000005842 heteroatom Chemical group 0.000 description 12
• 238000010898 silica gel chromatography Methods 0.000 description 12
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
• 125000004183 alkoxy alkyl group Chemical group 0.000 description 10
• 125000004448 alkyl carbonyl group Chemical group 0.000 description 10
• 125000004663 dialkyl amino group Chemical group 0.000 description 10
• 125000002911 monocyclic heterocycle group Chemical group 0.000 description 10
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
• 239000002253 acid Substances 0.000 description 9
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
• 239000003054 catalyst Substances 0.000 description 9
• 125000005265 dialkylamine group Chemical group 0.000 description 9
• 125000002757 morpholinyl group Chemical group 0.000 description 9
• 229910052760 oxygen Inorganic materials 0.000 description 9
• 239000001301 oxygen Substances 0.000 description 9
• 125000003386 piperidinyl group Chemical group 0.000 description 9
• 229910052938 sodium sulfate Inorganic materials 0.000 description 9
• 235000011152 sodium sulphate Nutrition 0.000 description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• 102000018208 Cannabinoid Receptor Human genes 0.000 description 8
• 108050007331 Cannabinoid receptor Proteins 0.000 description 8
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 8
• 239000013078 crystal Substances 0.000 description 8
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 8
• OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 8
• 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 8
• 239000012299 nitrogen atmosphere Substances 0.000 description 8
• 229910000027 potassium carbonate Inorganic materials 0.000 description 8
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 8
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 7
• 125000004644 alkyl sulfinyl group Chemical group 0.000 description 7
• 230000002140 halogenating effect Effects 0.000 description 7
• 239000003921 oil Substances 0.000 description 7
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 6
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
• ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 6
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
• 125000002252 acyl group Chemical group 0.000 description 6
• 239000000654 additive Substances 0.000 description 6
• 230000000996 additive effect Effects 0.000 description 6
• 125000003282 alkyl amino group Chemical group 0.000 description 6
• 125000002947 alkylene group Chemical group 0.000 description 6
• 235000019270 ammonium chloride Nutrition 0.000 description 6
• MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 6
• 125000004181 carboxyalkyl group Chemical group 0.000 description 6
• 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 6
• 239000010410 layer Substances 0.000 description 6
• 229910052763 palladium Inorganic materials 0.000 description 6
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
• BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 6
• 238000010992 reflux Methods 0.000 description 6
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
• 235000017557 sodium bicarbonate Nutrition 0.000 description 6
• 229910000029 sodium carbonate Inorganic materials 0.000 description 6
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
• RSPCKAHMRANGJZ-UHFFFAOYSA-N thiohydroxylamine Chemical compound SN RSPCKAHMRANGJZ-UHFFFAOYSA-N 0.000 description 6
• 125000004950 trifluoroalkyl group Chemical group 0.000 description 6
• LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
• 101000710899 Homo sapiens Cannabinoid receptor 1 Proteins 0.000 description 5
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
• SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 5
• 239000012190 activator Substances 0.000 description 5
• 150000001335 aliphatic alkanes Chemical class 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 5
• 229910000024 caesium carbonate Inorganic materials 0.000 description 5
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 5
• 229960005286 carbaryl Drugs 0.000 description 5
• CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 5
• 210000004027 cell Anatomy 0.000 description 5
• 125000004966 cyanoalkyl group Chemical group 0.000 description 5
• IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 5
• 150000002923 oximes Chemical class 0.000 description 5
• PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 5
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
• JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 5
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
• 244000025254 Cannabis sativa Species 0.000 description 4
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
• JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
• KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 4
• PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
• 125000002541 furyl group Chemical group 0.000 description 4
• 125000005059 halophenyl group Chemical group 0.000 description 4
• 239000001257 hydrogen Substances 0.000 description 4
• 229910052739 hydrogen Inorganic materials 0.000 description 4
• 239000005457 ice water Substances 0.000 description 4
• 239000011777 magnesium Substances 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 4
• NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
• 125000000168 pyrrolyl group Chemical group 0.000 description 4
• 238000001525 receptor binding assay Methods 0.000 description 4
• 229910052707 ruthenium Inorganic materials 0.000 description 4
• 125000001544 thienyl group Chemical group 0.000 description 4
• 125000003396 thiol group Chemical group [H]S* 0.000 description 4
• 125000004568 thiomorpholinyl group Chemical group 0.000 description 4
• ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
• FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 description 3
• PDNHLCRMUIGNBV-UHFFFAOYSA-N 1-pyridin-2-ylethanamine Chemical compound CC(N)C1=CC=CC=N1 PDNHLCRMUIGNBV-UHFFFAOYSA-N 0.000 description 3
• GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
• 102100036214 Cannabinoid receptor 2 Human genes 0.000 description 3
• 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 3
• 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 3
• QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000875075 Homo sapiens Cannabinoid receptor 2 Proteins 0.000 description 3
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
• 229910052783 alkali metal Inorganic materials 0.000 description 3
• 150000003973 alkyl amines Chemical group 0.000 description 3
• 230000003042 antagnostic effect Effects 0.000 description 3
• 239000005557 antagonist Substances 0.000 description 3
• JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
• 125000002618 bicyclic heterocycle group Chemical group 0.000 description 3
• 239000013058 crude material Substances 0.000 description 3
• NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 3
• 125000004982 dihaloalkyl group Chemical group 0.000 description 3
• YPXGHKWOJXQLQU-UHFFFAOYSA-N ethyl 5-amino-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C=1C=NNC=1N YPXGHKWOJXQLQU-UHFFFAOYSA-N 0.000 description 3
• BHMFBKSVLSRJAT-UHFFFAOYSA-N ethyl 5-amino-3-methylsulfanyl-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C1=C(N)NN=C1SC BHMFBKSVLSRJAT-UHFFFAOYSA-N 0.000 description 3
• GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 3
• 229910052736 halogen Inorganic materials 0.000 description 3
• OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
• 125000002632 imidazolidinyl group Chemical group 0.000 description 3
• 125000002883 imidazolyl group Chemical group 0.000 description 3
• 239000011630 iodine Substances 0.000 description 3
• 229910052740 iodine Inorganic materials 0.000 description 3
• 239000012948 isocyanate Substances 0.000 description 3
• KHBWTRFWQROKJZ-UHFFFAOYSA-N methyl 2-(2-chlorophenyl)acetate Chemical compound COC(=O)CC1=CC=CC=C1Cl KHBWTRFWQROKJZ-UHFFFAOYSA-N 0.000 description 3
• VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
• 125000001624 naphthyl group Chemical group 0.000 description 3
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
• 125000005936 piperidyl group Chemical group 0.000 description 3
• 235000011056 potassium acetate Nutrition 0.000 description 3
• NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 3
• 229910000160 potassium phosphate Inorganic materials 0.000 description 3
• 235000011009 potassium phosphates Nutrition 0.000 description 3
• 125000003226 pyrazolyl group Chemical group 0.000 description 3
• 125000000714 pyrimidinyl group Chemical group 0.000 description 3
• BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
• 239000001632 sodium acetate Substances 0.000 description 3
• 235000017281 sodium acetate Nutrition 0.000 description 3
• FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
• 235000019345 sodium thiosulphate Nutrition 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 125000003507 tetrahydrothiofenyl group Chemical group 0.000 description 3
• 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 description 3
• 125000003831 tetrazolyl group Chemical group 0.000 description 3
• 125000000335 thiazolyl group Chemical group 0.000 description 3
• GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 3
• AXJQVVLKUYCICH-OAQYLSRUSA-N (4s)-5-(4-chlorophenyl)-n-(4-chlorophenyl)sulfonyl-n'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide Chemical compound C=1C=C(Cl)C=CC=1C([C@H](C1)C=2C=CC=CC=2)=NN1C(=NC)NS(=O)(=O)C1=CC=C(Cl)C=C1 AXJQVVLKUYCICH-OAQYLSRUSA-N 0.000 description 2
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
• BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 2
• WOXWUZCRWJWTRT-UHFFFAOYSA-N 1-amino-1-cyclohexanecarboxylic acid Chemical compound OC(=O)C1(N)CCCCC1 WOXWUZCRWJWTRT-UHFFFAOYSA-N 0.000 description 2
• BASMANVIUSSIIM-UHFFFAOYSA-N 1-chloro-2-(chloromethyl)benzene Chemical compound ClCC1=CC=CC=C1Cl BASMANVIUSSIIM-UHFFFAOYSA-N 0.000 description 2
• PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 2
• PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
• 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
• OAQWCHBAEMBAJY-UHFFFAOYSA-N 6-(2-chlorophenyl)-7-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)O)C=NN2C=1C1=CC=C(Cl)C=C1 OAQWCHBAEMBAJY-UHFFFAOYSA-N 0.000 description 2
• 125000003341 7 membered heterocyclic group Chemical group 0.000 description 2
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
• 208000007848 Alcoholism Diseases 0.000 description 2
• ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
• KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 description 2
• 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 description 2
• 101710187022 Cannabinoid receptor 2 Proteins 0.000 description 2
• XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
• YUXIBTJKHLUKBD-UHFFFAOYSA-N Dibutyl succinate Chemical compound CCCCOC(=O)CCC(=O)OCCCC YUXIBTJKHLUKBD-UHFFFAOYSA-N 0.000 description 2
• QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
• GKQLYSROISKDLL-UHFFFAOYSA-N EEDQ Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 description 2
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
• FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 229930182555 Penicillin Natural products 0.000 description 2
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
• XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
• 208000028017 Psychotic disease Diseases 0.000 description 2
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
• CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 2
• YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 2
• 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• 150000001340 alkali metals Chemical class 0.000 description 2
• 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 2
• 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 2
• 125000005037 alkyl phenyl group Chemical group 0.000 description 2
• 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 2
• SRVFFFJZQVENJC-IHRRRGAJSA-N aloxistatin Chemical compound CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C SRVFFFJZQVENJC-IHRRRGAJSA-N 0.000 description 2
• BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 2
• 229910021529 ammonia Inorganic materials 0.000 description 2
• 239000001099 ammonium carbonate Substances 0.000 description 2
• 235000012501 ammonium carbonate Nutrition 0.000 description 2
• 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 2
• 239000004327 boric acid Substances 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
• 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
• 150000001924 cycloalkanes Chemical class 0.000 description 2
• 125000006310 cycloalkyl amino group Chemical group 0.000 description 2
• 230000018044 dehydration Effects 0.000 description 2
• 238000006297 dehydration reaction Methods 0.000 description 2
• CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 229960002097 dibutylsuccinate Drugs 0.000 description 2
• 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 description 2
• 125000005052 dihydropyrazolyl group Chemical group N1(NCC=C1)* 0.000 description 2
• 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 2
• BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 2
• MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
• FSAARXJNYMKMNS-UHFFFAOYSA-N ethyl 6-(2-chlorophenyl)-2-methylsulfanyl-7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)OCC)C(SC)=NN2C=1C1=CC=C(C(F)(F)F)C=C1 FSAARXJNYMKMNS-UHFFFAOYSA-N 0.000 description 2
• 125000004494 ethyl ester group Chemical group 0.000 description 2
• BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
• 150000004820 halides Chemical class 0.000 description 2
• 150000002367 halogens Chemical class 0.000 description 2
• 102000056693 human CNR2 Human genes 0.000 description 2
• ATBKVKDEMSGMTQ-UHFFFAOYSA-N hydrazine triphenylphosphane Chemical compound NN.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1 ATBKVKDEMSGMTQ-UHFFFAOYSA-N 0.000 description 2
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
• 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
• 125000002636 imidazolinyl group Chemical group 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 2
• 125000001786 isothiazolyl group Chemical group 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
• 240000004308 marijuana Species 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
• CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 description 2
• ORAKNQSHWMHCEY-UHFFFAOYSA-N methyl 2-pyridin-2-ylacetate Chemical compound COC(=O)CC1=CC=CC=N1 ORAKNQSHWMHCEY-UHFFFAOYSA-N 0.000 description 2
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
• 239000007800 oxidant agent Substances 0.000 description 2
• YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
• 229940049954 penicillin Drugs 0.000 description 2
• YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
• 150000003003 phosphines Chemical class 0.000 description 2
• 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
• 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
• 239000011698 potassium fluoride Substances 0.000 description 2
• 235000003270 potassium fluoride Nutrition 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 125000003072 pyrazolidinyl group Chemical group 0.000 description 2
• 125000002755 pyrazolinyl group Chemical group 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 239000002287 radioligand Substances 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 229920005989 resin Polymers 0.000 description 2
• 239000011347 resin Substances 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 2
• 229960002218 sodium chlorite Drugs 0.000 description 2
• 239000012312 sodium hydride Substances 0.000 description 2
• 229910000104 sodium hydride Inorganic materials 0.000 description 2
• SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 125000000547 substituted alkyl group Chemical group 0.000 description 2
• VEPTXBCIDSFGBF-UHFFFAOYSA-M tetrabutylazanium;fluoride;trihydrate Chemical compound O.O.O.[F-].CCCC[N+](CCCC)(CCCC)CCCC VEPTXBCIDSFGBF-UHFFFAOYSA-M 0.000 description 2
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
• 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 2
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
• 125000005942 tetrahydropyridyl group Chemical group 0.000 description 2
• RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 125000001984 thiazolidinyl group Chemical group 0.000 description 2
• ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 2
• 125000004952 trihaloalkoxy group Chemical group 0.000 description 2
• BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
• VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
• GHILZUOTUJGCDH-UHFFFAOYSA-N (1-methylcyclopropyl)azanium;chloride Chemical compound Cl.CC1(N)CC1 GHILZUOTUJGCDH-UHFFFAOYSA-N 0.000 description 1
• NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
• XDXHUSNUZZWGAJ-LLVKDONJSA-N (3R)-N-benzylthiolan-3-amine Chemical compound C=1C=CC=CC=1CN[C@@H]1CCSC1 XDXHUSNUZZWGAJ-LLVKDONJSA-N 0.000 description 1
• 125000006636 (C3-C8) cycloalkylcarbonyl group Chemical group 0.000 description 1
• 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 description 1
• 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 description 1
• KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
• CPAHOXOBYHMHDT-UHFFFAOYSA-N 1,3-dibromo-2,2-dimethoxypropane Chemical compound COC(CBr)(CBr)OC CPAHOXOBYHMHDT-UHFFFAOYSA-N 0.000 description 1
• KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
• KJDRSWPQXHESDQ-UHFFFAOYSA-N 1,4-dichlorobutane Chemical compound ClCCCCCl KJDRSWPQXHESDQ-UHFFFAOYSA-N 0.000 description 1
• IBXMKLPFLZYRQZ-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 IBXMKLPFLZYRQZ-UHFFFAOYSA-N 0.000 description 1
• VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
• LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
• YBZCSKVLXBOFSL-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopentane-1-carboxylic acid Chemical compound CC(C)(C)OC(=O)NC1(C(O)=O)CCCC1 YBZCSKVLXBOFSL-UHFFFAOYSA-N 0.000 description 1
• UZDHDPDJHBPQTQ-UHFFFAOYSA-N 1-aminocyclohexane-1-carbonitrile;hydron;chloride Chemical compound Cl.N#CC1(N)CCCCC1 UZDHDPDJHBPQTQ-UHFFFAOYSA-N 0.000 description 1
• GQEXBJOPGJUKIL-UHFFFAOYSA-N 1-aminocyclohexane-1-carboxamide Chemical compound NC(=O)C1(N)CCCCC1 GQEXBJOPGJUKIL-UHFFFAOYSA-N 0.000 description 1
• NILQLFBWTXNUOE-UHFFFAOYSA-N 1-aminocyclopentanecarboxylic acid Chemical compound OC(=O)C1(N)CCCC1 NILQLFBWTXNUOE-UHFFFAOYSA-N 0.000 description 1
• ALKWTKGPKKAZMN-UHFFFAOYSA-N 1-chloro-4-[chloro(phenyl)methyl]benzene Chemical compound C=1C=C(Cl)C=CC=1C(Cl)C1=CC=CC=C1 ALKWTKGPKKAZMN-UHFFFAOYSA-N 0.000 description 1
• DIZKLZKLNKQFGB-UHFFFAOYSA-N 1-methylcyclopropane-1-carboxylic acid Chemical compound OC(=O)C1(C)CC1 DIZKLZKLNKQFGB-UHFFFAOYSA-N 0.000 description 1
• GGYVTHJIUNGKFZ-UHFFFAOYSA-N 1-methylpiperidin-2-one Chemical compound CN1CCCCC1=O GGYVTHJIUNGKFZ-UHFFFAOYSA-N 0.000 description 1
• CFXRIYAZONSRSZ-UHFFFAOYSA-N 1-methylthiolan-1-amine Chemical compound CS1(N)CCCC1 CFXRIYAZONSRSZ-UHFFFAOYSA-N 0.000 description 1
• MHWMFBBXGBLALT-UHFFFAOYSA-N 1-o'-tert-butyl 1-o-methyl cyclopentane-1,1-dicarboxylate Chemical compound CC(C)(C)OC(=O)C1(C(=O)OC)CCCC1 MHWMFBBXGBLALT-UHFFFAOYSA-N 0.000 description 1
• 125000005955 1H-indazolyl group Chemical group 0.000 description 1
• BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical class NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 description 1
• XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 description 1
• TZGKYZWBZFXLSI-UHFFFAOYSA-N 2-(1-aminocyclopentyl)propan-2-ol;hydrochloride Chemical compound Cl.CC(C)(O)C1(N)CCCC1 TZGKYZWBZFXLSI-UHFFFAOYSA-N 0.000 description 1
• VMEPFMQBGKXQKU-UHFFFAOYSA-N 2-(2-chlorophenyl)-1-(4-chlorophenyl)ethanone Chemical compound C1=CC(Cl)=CC=C1C(=O)CC1=CC=CC=C1Cl VMEPFMQBGKXQKU-UHFFFAOYSA-N 0.000 description 1
• MEUPFZFYHFHTAR-UHFFFAOYSA-N 2-(2-chlorophenyl)-1-[4-(trifluoromethyl)phenyl]ethanone Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)CC1=CC=CC=C1Cl MEUPFZFYHFHTAR-UHFFFAOYSA-N 0.000 description 1
• GWZGZRQVYRSDIU-UHFFFAOYSA-N 2-(2-chlorophenyl)-3-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]prop-2-en-1-one Chemical compound C=1C=CC=C(Cl)C=1C(=CN(C)C)C(=O)C1=CC=C(C(F)(F)F)C=C1 GWZGZRQVYRSDIU-UHFFFAOYSA-N 0.000 description 1
• ZEMZPXWZVTUONV-UHFFFAOYSA-N 2-(2-dicyclohexylphosphanylphenyl)-n,n-dimethylaniline Chemical group CN(C)C1=CC=CC=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 ZEMZPXWZVTUONV-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• RJTFAXODZHCPEN-UHFFFAOYSA-N 2-amino-2-pyridin-2-ylacetamide Chemical compound NC(=O)C(N)C1=CC=CC=N1 RJTFAXODZHCPEN-UHFFFAOYSA-N 0.000 description 1
• OTURRDQKFBOBNZ-UHFFFAOYSA-N 2-benzylsulfanylprop-2-enoic acid Chemical compound OC(=O)C(=C)SCC1=CC=CC=C1 OTURRDQKFBOBNZ-UHFFFAOYSA-N 0.000 description 1
• 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
• FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 1
• APOYTRAZFJURPB-UHFFFAOYSA-N 2-methoxy-n-(2-methoxyethyl)-n-(trifluoro-$l^{4}-sulfanyl)ethanamine Chemical compound COCCN(S(F)(F)F)CCOC APOYTRAZFJURPB-UHFFFAOYSA-N 0.000 description 1
• GVCARDRZNAPXPT-UHFFFAOYSA-N 2-methylsulfanylprop-2-enoic acid Chemical compound CSC(=C)C(O)=O GVCARDRZNAPXPT-UHFFFAOYSA-N 0.000 description 1
• DQSQBZXDMHDHEO-UHFFFAOYSA-N 2-pyridin-2-ylpropan-2-amine Chemical compound CC(C)(N)C1=CC=CC=N1 DQSQBZXDMHDHEO-UHFFFAOYSA-N 0.000 description 1
• RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
• JKSIXVZIFHKAPJ-UHFFFAOYSA-N 2h-benzotriazole;hydrate Chemical compound O.C1=CC=C2NN=NC2=C1 JKSIXVZIFHKAPJ-UHFFFAOYSA-N 0.000 description 1
• LPCQBTAOTIZGAE-UHFFFAOYSA-N 2h-pyrimidine-1-carboxamide Chemical compound NC(=O)N1CN=CC=C1 LPCQBTAOTIZGAE-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• JEDSDHIXKWUWHC-UHFFFAOYSA-N 3-azaniumylthietane-3-carboxylate Chemical compound OC(=O)C1(N)CSC1 JEDSDHIXKWUWHC-UHFFFAOYSA-N 0.000 description 1
• RBSGNVCVLXKKFY-UHFFFAOYSA-N 3-oxooctanal Chemical compound CCCCCC(=O)CC=O RBSGNVCVLXKKFY-UHFFFAOYSA-N 0.000 description 1
• ROLMZTIHUMKEAI-UHFFFAOYSA-N 4,5-difluoro-2-hydroxybenzonitrile Chemical compound OC1=CC(F)=C(F)C=C1C#N ROLMZTIHUMKEAI-UHFFFAOYSA-N 0.000 description 1
• MCGBIXXDQFWVDW-UHFFFAOYSA-N 4,5-dihydro-1h-pyrazole Chemical class C1CC=NN1 MCGBIXXDQFWVDW-UHFFFAOYSA-N 0.000 description 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
• LRWRETFKIHKSJZ-UHFFFAOYSA-N 4-(ethyliminomethylideneamino)-n,n-dimethylbutan-1-amine;hydrochloride Chemical compound Cl.CCN=C=NCCCCN(C)C LRWRETFKIHKSJZ-UHFFFAOYSA-N 0.000 description 1
• DRNJIKRLQJRKMM-UHFFFAOYSA-N 4-(trifluoromethyl)benzonitrile Chemical compound FC(F)(F)C1=CC=C(C#N)C=C1 DRNJIKRLQJRKMM-UHFFFAOYSA-N 0.000 description 1
• FTTKMOOFKYOPQD-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxycarbonylamino]thiane-4-carboxylic acid Chemical compound CC(C)(C)OC(=O)NC1(C(O)=O)CCSCC1 FTTKMOOFKYOPQD-UHFFFAOYSA-N 0.000 description 1
• ASFXLCNDBDHZGC-UHFFFAOYSA-N 4-aminooxane-4-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)C1(N)CCOCC1 ASFXLCNDBDHZGC-UHFFFAOYSA-N 0.000 description 1
• CYWPCNCIUAEHBD-UHFFFAOYSA-N 4-aminothiane-4-carbonitrile Chemical compound N#CC1(N)CCSCC1 CYWPCNCIUAEHBD-UHFFFAOYSA-N 0.000 description 1
• HPJLSRXFFQYHTI-UHFFFAOYSA-N 4-aminothiane-4-carbonitrile;hydrochloride Chemical compound Cl.N#CC1(N)CCSCC1 HPJLSRXFFQYHTI-UHFFFAOYSA-N 0.000 description 1
• AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
• GJNGXPDXRVXSEH-UHFFFAOYSA-N 4-chlorobenzonitrile Chemical compound ClC1=CC=C(C#N)C=C1 GJNGXPDXRVXSEH-UHFFFAOYSA-N 0.000 description 1
• CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 1
• UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
• 125000002471 4H-quinolizinyl group Chemical group C=1(C=CCN2C=CC=CC12)* 0.000 description 1
• FYTLHYRDGXRYEY-UHFFFAOYSA-N 5-Methyl-3-pyrazolamine Chemical compound CC=1C=C(N)NN=1 FYTLHYRDGXRYEY-UHFFFAOYSA-N 0.000 description 1
• OTTCCTWDSXYEQK-UHFFFAOYSA-N 6-(2-bromophenyl)-7-(4-chlorophenyl)-2-sulfamoylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C=1C=CC=C(Br)C=1C=1C=NC2=C(C(O)=O)C(S(=O)(=O)N)=NN2C=1C1=CC=C(Cl)C=C1 OTTCCTWDSXYEQK-UHFFFAOYSA-N 0.000 description 1
• KBDGXSQDUIQSJX-UHFFFAOYSA-N 6-(2-bromophenyl)-7-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C=1C=CC=C(Br)C=1C=1C=NC2=C(C(=O)O)C=NN2C=1C1=CC=C(Cl)C=C1 KBDGXSQDUIQSJX-UHFFFAOYSA-N 0.000 description 1
• OYQIWOGVKBGQAZ-UHFFFAOYSA-N 6-(2-chlorophenyl)-2-methyl-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(O)=O)C(C)=NN2C=1C1=CC=CC=C1 OYQIWOGVKBGQAZ-UHFFFAOYSA-N 0.000 description 1
• QUFIWBPZXUEBDA-UHFFFAOYSA-N 6-(2-chlorophenyl)-7-(4-chlorophenyl)-2-(methanesulfonamido)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(O)=O)C(NS(=O)(=O)C)=NN2C=1C1=CC=C(Cl)C=C1 QUFIWBPZXUEBDA-UHFFFAOYSA-N 0.000 description 1
• XVAQVASMZZSYQH-UHFFFAOYSA-N 6-(2-chlorophenyl)-7-(4-chlorophenyl)-2-[methyl(methylsulfonyl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(O)=O)C(N(C)S(C)(=O)=O)=NN2C=1C1=CC=C(Cl)C=C1 XVAQVASMZZSYQH-UHFFFAOYSA-N 0.000 description 1
• ZUNMMVWFRITYCG-UHFFFAOYSA-N 6-(2-chlorophenyl)-7-(4-methylpiperidin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C1CC(C)CCN1C1=C(C=2C(=CC=CC=2)Cl)C=NC2=C(C(O)=O)C=NN12 ZUNMMVWFRITYCG-UHFFFAOYSA-N 0.000 description 1
• KCWBHSCMUKCZSX-UHFFFAOYSA-N 6-(2-chlorophenyl)-7-[4-(difluoromethyl)-2-fluorophenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)O)C=NN2C=1C1=CC=C(C(F)F)C=C1F KCWBHSCMUKCZSX-UHFFFAOYSA-N 0.000 description 1
• WJSVJJXYXJJMRU-UHFFFAOYSA-N 6-(2-chlorophenyl)-7-[4-(dimethylamino)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid Chemical compound C1=CC(N(C)C)=CC=C1C1=C(C=2C(=CC=CC=2)Cl)C=NC2=C(C(O)=O)C=NN12 WJSVJJXYXJJMRU-UHFFFAOYSA-N 0.000 description 1
• WXKDQMXDYXOKPT-UHFFFAOYSA-N 7-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine Chemical compound C1=CC(Cl)=CC=C1C1=CC=NC2=CC=NN12 WXKDQMXDYXOKPT-UHFFFAOYSA-N 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• RJYKFBMFAOUVQJ-UHFFFAOYSA-N C(=O)=C1NN2C(N=CC=C2)=C1 Chemical compound C(=O)=C1NN2C(N=CC=C2)=C1 RJYKFBMFAOUVQJ-UHFFFAOYSA-N 0.000 description 1
• MSEPJQIYSRZBQX-UHFFFAOYSA-N C1(=C(C=CC=C1)P(C1=C(C=CC=C1)C)C1=C(C=CC=C1)C)C.NN Chemical compound C1(=C(C=CC=C1)P(C1=C(C=CC=C1)C)C1=C(C=CC=C1)C)C.NN MSEPJQIYSRZBQX-UHFFFAOYSA-N 0.000 description 1
• MSIGCVKWJQIFQW-UHFFFAOYSA-N C1(=CC=CC=C1)P(=O)(C1=CC=CC=C1)N=[N+]=[N-].[N-]=[N+]=[N-] Chemical compound C1(=CC=CC=C1)P(=O)(C1=CC=CC=C1)N=[N+]=[N-].[N-]=[N+]=[N-] MSIGCVKWJQIFQW-UHFFFAOYSA-N 0.000 description 1
• KXNQHDJSDDWTFH-UHFFFAOYSA-N CC(CCCCCCCCCC([N+](=O)[O-])[N+](=O)[O-])(C)C Chemical compound CC(CCCCCCCCCC([N+](=O)[O-])[N+](=O)[O-])(C)C KXNQHDJSDDWTFH-UHFFFAOYSA-N 0.000 description 1
• APJFNWDLMYBTGU-UHFFFAOYSA-N CCOC(=O)C=1C=NN(C2=O)C=1NC=C2C1=CC=CC=C1Cl Chemical compound CCOC(=O)C=1C=NN(C2=O)C=1NC=C2C1=CC=CC=C1Cl APJFNWDLMYBTGU-UHFFFAOYSA-N 0.000 description 1
• RPQBJXDJRWGHEO-UHFFFAOYSA-N CCOC(C1=C2N=CC=C(C3=C(C4C5=CC=CC(C)=C5C=C4F)C=CC=C3)N2N=C1)=O Chemical compound CCOC(C1=C2N=CC=C(C3=C(C4C5=CC=CC(C)=C5C=C4F)C=CC=C3)N2N=C1)=O RPQBJXDJRWGHEO-UHFFFAOYSA-N 0.000 description 1
• GCHCABFZNOHDRC-UHFFFAOYSA-N COC1(CSC=C1)OC Chemical compound COC1(CSC=C1)OC GCHCABFZNOHDRC-UHFFFAOYSA-N 0.000 description 1
• KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
• BXOWUENTEJOTSB-UHFFFAOYSA-N ClC1=C(C=CC=C1)C1=CNC=2N(C1CCC=O)N=CC2C(=O)OCC Chemical compound ClC1=C(C=CC=C1)C1=CNC=2N(C1CCC=O)N=CC2C(=O)OCC BXOWUENTEJOTSB-UHFFFAOYSA-N 0.000 description 1
• SQMDXXZMYHLTNK-UHFFFAOYSA-N ClC1=C(C=CC=C1)C=1C=NC=2N(C1C1=CC=C(C=C1)CF)N=C(C2)C Chemical compound ClC1=C(C=CC=C1)C=1C=NC=2N(C1C1=CC=C(C=C1)CF)N=C(C2)C SQMDXXZMYHLTNK-UHFFFAOYSA-N 0.000 description 1
• 239000005749 Copper compound Substances 0.000 description 1
• PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
• XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 description 1
• YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
• 241001539473 Euphoria Species 0.000 description 1
• 206010015535 Euphoric mood Diseases 0.000 description 1
• QHYDTNJLNIPPER-UHFFFAOYSA-N FC1(C(C=CC=C1)B(O)O)C1=CC=C(C=C1)C Chemical compound FC1(C(C=CC=C1)B(O)O)C1=CC=C(C=C1)C QHYDTNJLNIPPER-UHFFFAOYSA-N 0.000 description 1
• FBONTKOWSGJBSH-UHFFFAOYSA-N FC1=CC=C(C=C1)OOB(OO)O Chemical compound FC1=CC=C(C=C1)OOB(OO)O FBONTKOWSGJBSH-UHFFFAOYSA-N 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 208000002705 Glucose Intolerance Diseases 0.000 description 1
• 239000007821 HATU Substances 0.000 description 1
• 208000004547 Hallucinations Diseases 0.000 description 1
• 206010019196 Head injury Diseases 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
• 208000035150 Hypercholesterolemia Diseases 0.000 description 1
• 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
• 208000031226 Hyperlipidaemia Diseases 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 208000026139 Memory disease Diseases 0.000 description 1
• 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
• YJXSCOJRQYUOEA-UHFFFAOYSA-N N-[[6-(2-chlorophenyl)-7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-pyridin-2-ylethanamine Chemical compound ClC1=C(C=CC=C1)C=1C=NC=2N(C1C1=CC=C(C=C1)C(F)(F)F)N=CC2CNC(C)C2=NC=CC=C2 YJXSCOJRQYUOEA-UHFFFAOYSA-N 0.000 description 1
• CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
• RDEYCMZLQCXZOJ-UHFFFAOYSA-N N1C(=CC2=CC=CC=C12)C1=NN2C(N=CC(=C2C2=CC=C(C=C2)Cl)C2=C(C=CC=C2)Cl)=C1 Chemical compound N1C(=CC2=CC=CC=C12)C1=NN2C(N=CC(=C2C2=CC=C(C=C2)Cl)C2=C(C=CC=C2)Cl)=C1 RDEYCMZLQCXZOJ-UHFFFAOYSA-N 0.000 description 1
• LFOMGBBERKOUPQ-UHFFFAOYSA-N NS(F)(F)F Chemical compound NS(F)(F)F LFOMGBBERKOUPQ-UHFFFAOYSA-N 0.000 description 1
• DFONVBGZXVCNBS-JHRLVUGGSA-N N[C@H](CCSC)CO.N[C@H](CCSC)C(=O)O Chemical compound N[C@H](CCSC)CO.N[C@H](CCSC)C(=O)O DFONVBGZXVCNBS-JHRLVUGGSA-N 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• SHYFFEXVFBQVKH-UHFFFAOYSA-N S-cyclobutylthiohydroxylamine Chemical compound C1(CCC1)SN SHYFFEXVFBQVKH-UHFFFAOYSA-N 0.000 description 1
• 239000005708 Sodium hypochlorite Substances 0.000 description 1
• 208000011641 Spinocerebellar disease Diseases 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
• 239000012317 TBTU Substances 0.000 description 1
• CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 1
• 235000010724 Wisteria floribunda Nutrition 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• OIHWXZDQKORVRT-UHFFFAOYSA-N [6-(2-chlorophenyl)-7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-2-yl]urea Chemical compound ClC1=C(C=CC=C1)C=1C=NC=2N(C1C1=CC=C(C=C1)C(F)(F)F)N=C(C2)NC(=O)N OIHWXZDQKORVRT-UHFFFAOYSA-N 0.000 description 1
• PRDVTPSOLVJMEU-UHFFFAOYSA-L [Ni](Cl)Cl.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.[Ru] Chemical compound [Ni](Cl)Cl.C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.[Ru] PRDVTPSOLVJMEU-UHFFFAOYSA-L 0.000 description 1
• FMTCJZPWLNDVOB-UHFFFAOYSA-N [Ni].C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.BrC1=C(C=2CC3=CC=CC=C3C2C=C1)Br Chemical compound [Ni].C1(=CC=CC=C1)P(C1=CC=CC=C1)C1=CC=CC=C1.BrC1=C(C=2CC3=CC=CC=C3C2C=C1)Br FMTCJZPWLNDVOB-UHFFFAOYSA-N 0.000 description 1
• 150000008065 acid anhydrides Chemical class 0.000 description 1
• 238000005903 acid hydrolysis reaction Methods 0.000 description 1
• 238000010306 acid treatment Methods 0.000 description 1
• 125000004442 acylamino group Chemical group 0.000 description 1
• 238000011360 adjunctive therapy Methods 0.000 description 1
• 201000007930 alcohol dependence Diseases 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 150000001342 alkaline earth metals Chemical class 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 150000004703 alkoxides Chemical class 0.000 description 1
• 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
• 125000005036 alkoxyphenyl group Chemical group 0.000 description 1
• 125000005094 alkyl carbonyl amino alkyl group Chemical group 0.000 description 1
• 150000001350 alkyl halides Chemical class 0.000 description 1
• 125000005154 alkyl sulfonyl amino alkyl group Chemical group 0.000 description 1
• 125000006383 alkylpyridyl group Chemical group 0.000 description 1
• 235000011114 ammonium hydroxide Nutrition 0.000 description 1
• 229940025084 amphetamine Drugs 0.000 description 1
• 230000036592 analgesia Effects 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 229940124332 anorexigenic agent Drugs 0.000 description 1
• 230000002891 anorexigenic effect Effects 0.000 description 1
• 239000000730 antalgic agent Substances 0.000 description 1
• 229940045799 anthracyclines and related substance Drugs 0.000 description 1
• 125000005427 anthranyl group Chemical group 0.000 description 1
• PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
• 150000004056 anthraquinones Chemical class 0.000 description 1
• 239000000883 anti-obesity agent Substances 0.000 description 1
• 239000000935 antidepressant agent Substances 0.000 description 1
• 229940005513 antidepressants Drugs 0.000 description 1
• 229940125710 antiobesity agent Drugs 0.000 description 1
• 239000000164 antipsychotic agent Substances 0.000 description 1
• 229940005529 antipsychotics Drugs 0.000 description 1
• 239000002249 anxiolytic agent Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 239000012300 argon atmosphere Substances 0.000 description 1
• 125000003710 aryl alkyl group Chemical group 0.000 description 1
• 125000005129 aryl carbonyl group Chemical group 0.000 description 1
• 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 230000003416 augmentation Effects 0.000 description 1
• 150000001540 azides Chemical class 0.000 description 1
• 125000004931 azocinyl group Chemical group N1=C(C=CC=CC=C1)* 0.000 description 1
• 125000003943 azolyl group Chemical group 0.000 description 1
• 229940125717 barbiturate Drugs 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
• 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
• 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
• AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
• 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 239000004305 biphenyl Substances 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• OJKZEZMAPKWHTG-UHFFFAOYSA-N bis(2h-triazol-4-yl)methanone Chemical compound C=1NN=NC=1C(=O)C1=CNN=N1 OJKZEZMAPKWHTG-UHFFFAOYSA-N 0.000 description 1
• 229910052797 bismuth Inorganic materials 0.000 description 1
• JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
• 229910052794 bromium Inorganic materials 0.000 description 1
• IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 1
• 125000005242 carbamoyl alkyl group Chemical group 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 229920001429 chelating resin Polymers 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 239000000460 chlorine Substances 0.000 description 1
• 229910052801 chlorine Inorganic materials 0.000 description 1
• MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
• XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
• 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
• 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
• 150000001860 citric acid derivatives Chemical class 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 229960003920 cocaine Drugs 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 150000001880 copper compounds Chemical class 0.000 description 1
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
• 208000029078 coronary artery disease Diseases 0.000 description 1
• 125000004802 cyanophenyl group Chemical group 0.000 description 1
• WEMTXCOQGNENQZ-UHFFFAOYSA-N cyclobutanethiol Chemical compound SC1CCC1 WEMTXCOQGNENQZ-UHFFFAOYSA-N 0.000 description 1
• 125000006638 cyclopentyl carbonyl group Chemical group 0.000 description 1
• 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• RSSPNKIJFWFVRV-UHFFFAOYSA-N diazomethyl(trimethyl)silane;ethoxyethane Chemical compound CCOCC.C[Si](C)(C)C=[N+]=[N-] RSSPNKIJFWFVRV-UHFFFAOYSA-N 0.000 description 1
• WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
• CVKBMWWNKUWISK-UHFFFAOYSA-L dichloromethane;dichloropalladium Chemical compound ClCCl.Cl[Pd]Cl CVKBMWWNKUWISK-UHFFFAOYSA-L 0.000 description 1
• XLQDQRMFMXYSQS-UHFFFAOYSA-N dichloromethane;hydrochloride Chemical compound Cl.ClCCl XLQDQRMFMXYSQS-UHFFFAOYSA-N 0.000 description 1
• ZBQUMMFUJLOTQC-UHFFFAOYSA-L dichloronickel;3-diphenylphosphanylpropyl(diphenyl)phosphane Chemical compound Cl[Ni]Cl.C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 ZBQUMMFUJLOTQC-UHFFFAOYSA-L 0.000 description 1
• LCSNDSFWVKMJCT-UHFFFAOYSA-N dicyclohexyl-(2-phenylphenyl)phosphane Chemical group C1CCCCC1P(C=1C(=CC=CC=1)C=1C=CC=CC=1)C1CCCCC1 LCSNDSFWVKMJCT-UHFFFAOYSA-N 0.000 description 1
• ZWWWLCMDTZFSOO-UHFFFAOYSA-N diethoxyphosphorylformonitrile Chemical compound CCOP(=O)(C#N)OCC ZWWWLCMDTZFSOO-UHFFFAOYSA-N 0.000 description 1
• FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• PBWZKZYHONABLN-UHFFFAOYSA-N difluoroacetic acid Chemical compound OC(=O)C(F)F PBWZKZYHONABLN-UHFFFAOYSA-N 0.000 description 1
• 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 1
• 125000005436 dihydrobenzothiophenyl group Chemical group S1C(CC2=C1C=CC=C2)* 0.000 description 1
• 125000004609 dihydroquinazolinyl group Chemical group N1(CN=CC2=CC=CC=C12)* 0.000 description 1
• SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
• 230000006806 disease prevention Effects 0.000 description 1
• CNXMDTWQWLGCPE-UHFFFAOYSA-N ditert-butyl-(2-phenylphenyl)phosphane Chemical group CC(C)(C)P(C(C)(C)C)C1=CC=CC=C1C1=CC=CC=C1 CNXMDTWQWLGCPE-UHFFFAOYSA-N 0.000 description 1
• 206010013663 drug dependence Diseases 0.000 description 1
• KUAFMPWKUNNUEC-UHFFFAOYSA-N ethyl 1-aminocyclohexane-1-carboxylate Chemical compound CCOC(=O)C1(N)CCCCC1 KUAFMPWKUNNUEC-UHFFFAOYSA-N 0.000 description 1
• KNOQQEWWHOMZMV-UHFFFAOYSA-N ethyl 2-(hydroxymethyl)-7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C(C)OC(=O)C=1C(=NN2C1N=CC=C2C2=CC=C(C=C2)C(F)(F)F)CO KNOQQEWWHOMZMV-UHFFFAOYSA-N 0.000 description 1
• MPGZEYSHAIHWLR-UHFFFAOYSA-N ethyl 2-amino-6-(2-chlorophenyl)-7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)OCC)C(N)=NN2C=1C1=CC=C(C(F)(F)F)C=C1 MPGZEYSHAIHWLR-UHFFFAOYSA-N 0.000 description 1
• JSGIQPUPKABCCE-UHFFFAOYSA-N ethyl 2-benzylsulfanyl-6-(2-chlorophenyl)-7-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound N=1N2C(C=3C=CC(Cl)=CC=3)=C(C=3C(=CC=CC=3)Cl)C=NC2=C(C(=O)OCC)C=1SCC1=CC=CC=C1 JSGIQPUPKABCCE-UHFFFAOYSA-N 0.000 description 1
• HZRZBLREEBMRKK-UHFFFAOYSA-N ethyl 2-benzylsulfanyl-7-chloro-6-(2-chlorophenyl)pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound N=1N2C(Cl)=C(C=3C(=CC=CC=3)Cl)C=NC2=C(C(=O)OCC)C=1SCC1=CC=CC=C1 HZRZBLREEBMRKK-UHFFFAOYSA-N 0.000 description 1
• YEFGESYEDXZBQL-UHFFFAOYSA-N ethyl 2-cyano-3-(1,3-dioxolan-2-yl)prop-2-enoate Chemical compound CCOC(=O)C(C#N)=CC1OCCO1 YEFGESYEDXZBQL-UHFFFAOYSA-N 0.000 description 1
• ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
• KEIURBFXGPZFQZ-UHFFFAOYSA-N ethyl 3-amino-5-(difluoromethyl)-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C=1C(N)=NNC=1C(F)F KEIURBFXGPZFQZ-UHFFFAOYSA-N 0.000 description 1
• WOCMIZZYXHVSPS-UHFFFAOYSA-N ethyl 3-amino-5-methyl-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C1=C(C)NN=C1N WOCMIZZYXHVSPS-UHFFFAOYSA-N 0.000 description 1
• VJPXHHVSQUQQGL-UHFFFAOYSA-N ethyl 4-aminothiane-4-carboxylate Chemical compound CCOC(=O)C1(N)CCSCC1 VJPXHHVSQUQQGL-UHFFFAOYSA-N 0.000 description 1
• ZNGPIBVNKANYRR-UHFFFAOYSA-N ethyl 5-(2-chlorophenyl)-7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound ClC1=C(C=CC=C1)C1=NC=2N(C(=C1)C1=CC=C(C=C1)C(F)(F)F)N=CC2C(=O)OCC ZNGPIBVNKANYRR-UHFFFAOYSA-N 0.000 description 1
• VPVMDWHULNALMW-UHFFFAOYSA-N ethyl 5-[[2-(2-chlorophenyl)-3-methoxy-3-oxoprop-1-enyl]amino]-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C1=CNN=C1NC=C(C(=O)OC)C1=CC=CC=C1Cl VPVMDWHULNALMW-UHFFFAOYSA-N 0.000 description 1
• FCQGHSMTJVCLTO-UHFFFAOYSA-N ethyl 5-amino-3-(2-hydroxyethoxy)-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C=1C(N)=NNC=1OCCO FCQGHSMTJVCLTO-UHFFFAOYSA-N 0.000 description 1
• IAAGUDBUJMGWPL-UHFFFAOYSA-N ethyl 5-amino-3-benzylsulfanyl-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C1=C(N)NN=C1SCC1=CC=CC=C1 IAAGUDBUJMGWPL-UHFFFAOYSA-N 0.000 description 1
• XZSMSBCESPJFGM-UHFFFAOYSA-N ethyl 6-(2-chlorophenyl)-2-pyrrolidin-1-yl-7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)OCC)C(N3CCCC3)=NN2C=1C1=CC=C(C(F)(F)F)C=C1 XZSMSBCESPJFGM-UHFFFAOYSA-N 0.000 description 1
• DIYNFAWZKNXCLS-UHFFFAOYSA-N ethyl 6-(2-chlorophenyl)-7-(4-chlorophenyl)-2-(methanesulfonamido)pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)OCC)C(NS(C)(=O)=O)=NN2C=1C1=CC=C(Cl)C=C1 DIYNFAWZKNXCLS-UHFFFAOYSA-N 0.000 description 1
• NINNOGBGFLSIMP-UHFFFAOYSA-N ethyl 6-(2-chlorophenyl)-7-(4-methylpiperidin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)OCC)C=NN2C=1N1CCC(C)CC1 NINNOGBGFLSIMP-UHFFFAOYSA-N 0.000 description 1
• PJGIZXNLECIOHA-UHFFFAOYSA-N ethyl 6-(2-chlorophenyl)-7-[4-(difluoromethyl)-2-fluorophenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C=1C=CC=C(Cl)C=1C=1C=NC2=C(C(=O)OCC)C=NN2C=1C1=CC=C(C(F)F)C=C1F PJGIZXNLECIOHA-UHFFFAOYSA-N 0.000 description 1
• VFHCKFGGCPCZCF-UHFFFAOYSA-N ethyl 6-(2-chlorophenyl)-7-[4-(trifluoromethyl)phenyl]-2-[(triphenyl-$l^{5}-phosphanylidene)amino]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound N=1N2C(C=3C=CC(=CC=3)C(F)(F)F)=C(C=3C(=CC=CC=3)Cl)C=NC2=C(C(=O)OCC)C=1N=P(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHCKFGGCPCZCF-UHFFFAOYSA-N 0.000 description 1
• VHWYPBIFKOAZLH-UHFFFAOYSA-N ethyl 7-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxylate Chemical compound C(C)OC(=O)C=1C=NN2C1N=CC=C2C2=CC=C(C=C2)C(F)(F)F VHWYPBIFKOAZLH-UHFFFAOYSA-N 0.000 description 1
• 125000006534 ethyl amino methyl group Chemical group [H]N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
• FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
• 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• 235000019253 formic acid Nutrition 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• 238000005227 gel permeation chromatography Methods 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000000380 hallucinogen Substances 0.000 description 1
• 230000026030 halogenation Effects 0.000 description 1
• 238000005658 halogenation reaction Methods 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 125000005223 heteroarylcarbonyl group Chemical group 0.000 description 1
• 238000005984 hydrogenation reaction Methods 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 1
• MNUOZFHYBCRUOD-UHFFFAOYSA-N hydroxyphthalic acid Natural products OC(=O)C1=CC=CC(O)=C1C(O)=O MNUOZFHYBCRUOD-UHFFFAOYSA-N 0.000 description 1
• 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
• 201000008980 hyperinsulinism Diseases 0.000 description 1
• 208000006575 hypertriglyceridemia Diseases 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
• PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
• 125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
• 125000005956 isoquinolyl group Chemical group 0.000 description 1
• SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
• 229910000103 lithium hydride Inorganic materials 0.000 description 1
• 238000011866 long-term treatment Methods 0.000 description 1
• 231100000053 low toxicity Toxicity 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 230000003340 mental effect Effects 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
• 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
• MTPXRXOMKRLUMU-UHFFFAOYSA-N methyl 1-aminocyclohexane-1-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1(N)CCCCC1 MTPXRXOMKRLUMU-UHFFFAOYSA-N 0.000 description 1
• KFILTGBQFNYAQZ-UHFFFAOYSA-N methyl 2H-thiopyran-4-carboxylate Chemical compound S1CC=C(C=C1)C(=O)OC KFILTGBQFNYAQZ-UHFFFAOYSA-N 0.000 description 1
• GZHKJVANRCMTJE-UHFFFAOYSA-N methyl 3-amino-5-(trifluoromethyl)-1h-pyrazole-4-carboxylate Chemical compound COC(=O)C=1C(N)=NNC=1C(F)(F)F GZHKJVANRCMTJE-UHFFFAOYSA-N 0.000 description 1
• XVJNQOQOGOJSLW-UHFFFAOYSA-N methyl 3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate Chemical compound COC(=O)C(C#N)=C(Cl)C(F)(F)F XVJNQOQOGOJSLW-UHFFFAOYSA-N 0.000 description 1
• AZFBPYNPITWILD-UHFFFAOYSA-N methyl 4-aminooxane-4-carboxylate Chemical compound COC(=O)C1(N)CCOCC1 AZFBPYNPITWILD-UHFFFAOYSA-N 0.000 description 1
• 229940102396 methyl bromide Drugs 0.000 description 1
• ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 1
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
• DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
• 125000006384 methylpyridyl group Chemical group 0.000 description 1
• 235000010755 mineral Nutrition 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 239000012452 mother liquor Substances 0.000 description 1
• UFSFYCIIKGJKSN-UHFFFAOYSA-N n,n-diethylethanamine;n-ethylethanamine Chemical compound CCNCC.CCN(CC)CC UFSFYCIIKGJKSN-UHFFFAOYSA-N 0.000 description 1
• JFCHSQDLLFJHOA-UHFFFAOYSA-N n,n-dimethylsulfamoyl chloride Chemical compound CN(C)S(Cl)(=O)=O JFCHSQDLLFJHOA-UHFFFAOYSA-N 0.000 description 1
• HJPHMPYPXOYPBI-UHFFFAOYSA-N n-chlorobutan-1-imine Chemical compound CCCC=NCl HJPHMPYPXOYPBI-UHFFFAOYSA-N 0.000 description 1
• 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
• 239000004081 narcotic agent Substances 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 229960002715 nicotine Drugs 0.000 description 1
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
• 229940127240 opiate Drugs 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 150000003891 oxalate salts Chemical class 0.000 description 1
• 125000000160 oxazolidinyl group Chemical group 0.000 description 1
• 150000002926 oxygen Chemical class 0.000 description 1
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
• 150000002941 palladium compounds Chemical class 0.000 description 1
• MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
• LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
• UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachloro-phenol Natural products OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• 229950010883 phencyclidine Drugs 0.000 description 1
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
• 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
• FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
• 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
• 125000004193 piperazinyl group Chemical group 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 150000004032 porphyrins Chemical class 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
• NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
• 229910000105 potassium hydride Inorganic materials 0.000 description 1
• 201000009104 prediabetes syndrome Diseases 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• 125000002098 pyridazinyl group Chemical group 0.000 description 1
• 125000005400 pyridylcarbonyl group Chemical group N1=C(C=CC=C1)C(=O)* 0.000 description 1
• ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
• 125000006085 pyrrolopyridyl group Chemical group 0.000 description 1
• 238000013139 quantization Methods 0.000 description 1
• 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
• 125000005493 quinolyl group Chemical group 0.000 description 1
• 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
• YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 1
• GHPHCACQRYSXSS-UHFFFAOYSA-N ruthenium;tricyclohexylphosphane Chemical compound [Ru].C1CCCCC1P(C1CCCCC1)C1CCCCC1 GHPHCACQRYSXSS-UHFFFAOYSA-N 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
• 235000009518 sodium iodide Nutrition 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• 235000010265 sodium sulphite Nutrition 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000012453 solvate Substances 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 125000003003 spiro group Chemical group 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 201000009032 substance abuse Diseases 0.000 description 1
• 231100000736 substance abuse Toxicity 0.000 description 1
• 125000005415 substituted alkoxy group Chemical group 0.000 description 1
• 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 229940124530 sulfonamide Drugs 0.000 description 1
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
• 150000003461 sulfonyl halides Chemical class 0.000 description 1
• 150000003463 sulfur Chemical class 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• QEPHTDYJBATZED-UHFFFAOYSA-N tert-butyl N-(thiolan-3-yl)carbamate Chemical compound CC(C)(C)OC(=O)NC1CCSC1 QEPHTDYJBATZED-UHFFFAOYSA-N 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
• BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
• XDLNRRRJZOJTRW-UHFFFAOYSA-N thiohypochlorous acid Chemical compound ClS XDLNRRRJZOJTRW-UHFFFAOYSA-N 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• 125000004953 trihalomethyl group Chemical group 0.000 description 1
• JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 1
• 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
• LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 238000010792 warming Methods 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1
• 229940102001 zinc bromide Drugs 0.000 description 1
• AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical group N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 description 1
• 125000004933 β-carbolinyl group Chemical group C1(=NC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1